Burning Rock Biotech Stock Forecast

Buy candidate since Aug 10, 2026

The Burning Rock Biotech Limited stock price gained 23.23% on the last trading day (Monday, 10th Aug 2026), rising from $8.81 to $10.86. During the last trading day the stock fluctuated 4.09% from a day low at $10.64 to a day high of $11.08. The price has fallen in 5 of the last 10 days but is still up by 15.5% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 19 thousand more shares were traded than the day before. In total, 21 thousand shares were bought and sold for approximately $225.02 thousand.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $9.57, a level that may pose a second chance to hit a runner. According to fan-theory $15.51 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

BNR Signals & Forecast

The Burning Rock Biotech Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $9.16 and $9.37. A breakdown below any of these levels will issue sell signals. Burning Rock Biotech Limited has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -7.60%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Burning Rock Biotech Limited stock

Burning Rock Biotech Limited finds support from accumulated volume at $10.75 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.435 between high and low, or 4.09%. For the last week, the stock has had daily average volatility of 2.62%.

Our recommended stop-loss: $10.41 (-4.10%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 23 days ago.)

Trading Expectations (BNR) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Burning Rock Biotech Limited to open at $10.86, and during the day (based on 14 day Average True Range), to move between $10.54 and $11.18, which gives a possible trading interval of +/-$0.643 (+/-6.10%) up or down from last closing price. If Burning Rock Biotech Limited takes out the full calculated possible swing range there will be an estimated 6.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.75 (1.03%) than the resistance at $11.30 (4.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Burning Rock Biotech Limited stock A Buy?

Several short-term signals are positive and the break-up from the falling trend indicates a possible shift for a trend. We believe that the prices around the breaking point will indicate particularly good levels, but we also believe that the current level will hold a possible good buy level for the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.936 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $10.86 ( 0.0037%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk